Phylogica is a life sciences platform technology company focussing on delivering biologic drugs intracellularly with our proprietary library and cell penetrating peptides.
Phylogica Limited (ASX: PYC) is a biotech company focused on commercialising its intracellular drug delivery platform and panning its Phylomer libraries to identify drug cargoes for development against a wide range of disease targets. Phylogica controls access to the world's most structurally diverse source of peptides called Phylomers, which have the ability to act as effective drug delivery agents and drug cargoes, penetrating cell walls to reach previously ‘undruggable’ targets across a range of disease types. Phylogica’s platform of proprietary cell penetration peptides is showing promise in delivering a diverse range of drug cargoes into cells, and the company’s lead asset program has identified a phylomer which can inhibit Myc, a protein responsible for the regulation of cancer cell growth. The company has collaborations with several pharmaceutical companies including Roche, Medimmune, Pfizer, Janssen and Genetech.
15/10/2018 17:20:00
Notice is hereby given that the Annual General Meeting of the Shareholders of Phylogica Limited will be held at Level 5, Perth Children's Hospital, 15 Hospital Avenue, Nedlands, Western Australia …
Company News /
by Adrian Tan -
19 days ago
17 Dec 2024 - PYC Therapeutics (ASX:PYC) has announced the nomination of its fourth clinical drug candidate, PYC-002, targeting Phelan-McDermid Syndrome (PMS), a rare neurodevelopm…
Company News /
by Adrian Tan -
A month ago
27 Nov 2024 - PYC Therapeutics (ASX:PYC) has announced plans to advance its investigational drug candidate, PYC-003, into human clinical trials for Autosomal Dominant Polycystic Ki…
Company News /
by Adrian Tan -
2 months ago
25 Oct 2024 - PYC Therapeutics (ASX:PYC) has announced significant progress in its efforts to develop RNA-based precision medicines for genetic diseases.
Company News /
by Adrian Tan -
2 months ago
21 Oct 2024 - PYC Therapeutics (ASX:PYC) has received Orphan Drug Designation from the US Food and Drug Administration for its drug candidate VP-001, aimed at treating Retinitis Pi…
Market Reports /
by Rachael Jones -
3 years ago
02 Mar 2021 - Following leads from US markets, the ASX looks set to open higher this morning – all three major US equity benchmarks rose. Major sovereign bonds rallied across the g…
Market Reports /
by Katrina Bullock -
5 years ago
04 Oct 2019 - Despite a strong session today, over the week the market has lost 199 points or 3.1%. Plus sized retailer, City Chic Collective (ASX:CCX) has purchased the e-commerce…
Interviews /
by Jessica Amir -
6 years ago
26 Feb 2018 - Phylogica Limited (ASX:PYC) CEO Stephanie Unwin talks about highlights from the company's December 2017 quarterly update.
Market Reports /
by Jessica Ellerm -
6 years ago
08 Jan 2018 - 4th straight day of gains: Aus shares close 0.13% higher. Vocus Group (ASX:VOC) leads gains, up 3.82%, Telecommunications sector best performer, Materials slide. SPI…
Company Presentations /
by -
7 years ago
04 Dec 2017 - Phylogica Limited (ASX:PYC) CEO, Stephanie Unwin and Dr Katrin Hoffmann, Director Scientific Operations talk about the company’s strategy, scientific platform and dir…
Interviews /
by Clive Tompkins -
7 years ago
04 Dec 2017 - Phylogica Limited (ASX:PYC) CEO, Stephanie Unwin talks about the company’s strategy and platform direction following its 2017 AGM.
Company Presentations /
by -
7 years ago
19 Sep 2017 - Phylogica (ASX:PYC) CEO, Stephanie Unwin, discusses the company's commercial focus on improving drug delivery.
Interviews /
by Jessica Amir -
7 years ago
19 Sep 2017 - Phylogica Limited (ASX:PYC) CEO Stephanie Unwin discusses the company’s drug delivery platform technology and opportunity to deliver therapeutics to previously undrug…
Market Reports /
by Roma Christian -
7 years ago
25 Jul 2017 - Nasdaq closes at record high: ASX to open higher. Phylogica Limited (ASX:PYC) appoints Mr Kevin Hart as Company Secretary and Chief Financial Officer, replacing retir…
Market Reports /
by -
14 years ago
20 Dec 2010 - Aus shares close in the red. Engineering consultancy firm Coffey International Ltd (ASX: COF) has announced a further round of job cuts in order to reduce costs which…